By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
CHOOSE YOUR LANGUAGE
CHOOSE YOUR LANGUAGE
互联网新闻信息许可证10120180008
Disinformation report hotline: 010-85061466
Iga Swiatek hits a shot during a practice session ahead of the United Cup in Sydney, Australia, December 27, 2024. /CFP
At the United Cup, Iga Swiatek said she doesn't expect the World Anti-Doping Agency to appeal the one-month suspension she recently served, after testing positive for banned substance in August. The International Tennis Integrity Agency accepted her explanation that the result was caused by a contaminated dose of melatonin.
The World No. 2 is preparing to lead Poland in Group B against the Czech Republic and Norway, at the season-opening mixed team event in Sydney.
"I'm not expecting an appeal, but I have, kind of, no influence on what's going to happen and, but, I can say from the process that I went through, and how they treated me from the beginning that it seemed, you know, fair for me. I managed to give the source pretty quickly," said Swiatek.
"That's why the case closed, you know, pretty quickly, but still I didn't play tournaments, and I kind of, I got a fine, small one, symbolic one, but it's over now. So I guess, in my opinion, it was a fair process, and I trust ITIA (International Tennis Integrity Agency) that any case they do, they're going to treat every player the same way and fairly," she concluded.